UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

Arthritis & rheumatology (Hoboken, N.J.), 2020-12, Vol.72 (12), p.1990-1997

2020

Volltextzugriff (PDF)

Fracture mortality: associations with epidemiology and osteoporosis treatment

Nature reviews. Endocrinology, 2014-10, Vol.10 (10), p.592-602

2014

Volltextzugriff (PDF)

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

Annals of internal medicine, 2020-06, Vol.172 (12), p.819-821

2020

Volltextzugriff (PDF)

SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2022-05, Vol.74 (5), p.766-775

2022

Volltextzugriff (PDF)

Patient‐Reported Outcomes in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Are the Answers in Front of Our Noses?

Arthritis care & research (2010), 2024-10, Vol.76 (10), p.1353-1354

2024

Volltextzugriff (PDF)

Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA‐Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide

Arthritis care & research (2010), 2024-02, Vol.76 (2), p.288-294

2024

Volltextzugriff (PDF)

Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications

Therapeutic Advances in Musculoskeletal Disease, 2016-08, Vol.8 (4), p.145-159

2016

Volltextzugriff (PDF)

Where did that trial go? Unpublished clinical trials in rheumatology and potential implications

Rheumatology (Oxford, England), 2023-12, Vol.62 (12), p.3778-3779

2023

Volltextzugriff (PDF)

Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152154-152154, Article 152154

2023

Volltextzugriff (PDF)

Navigating use of rituximab during the COVID-19 pandemic

The Lancet. Rheumatology, 2023-02, Vol.5 (2), p.e63-e64

2023

Volltextzugriff (PDF)

Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention

Journal of rheumatology, 2023-01, Vol.50 (1), p.3-5

2023

Volltextzugriff (PDF)

Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment

Current allergy and asthma reports, 2020-10, Vol.20 (10), p.56-56, Article 56

2020

Volltextzugriff (PDF)

Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019

Rheumatic diseases clinics of North America, 2023-08, Vol.49 (3), p.695-711

2023

Volltextzugriff (PDF)

The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World

Journal of rheumatology, 2021-10, Vol.48 (10), p.1501-1503

2021

Volltextzugriff (PDF)

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

Annals of the rheumatic diseases, 2020-06, Vol.79 (6), p.734-736

2020

Volltextzugriff (PDF)

Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the American College of Rheumatology RISE Registry

Arthritis care & research (2010), 2024-02, Vol.76 (2), p.259-264

2024

Volltextzugriff (PDF)

Current perspective on infections and mitigation strategies in primary systemic vasculitis

Current rheumatology reports, 2024-08, Vol.26 (8), p.279-289

2024

Volltextzugriff (PDF)

Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs – Analysis of a national claims database

Seminars in arthritis and rheumatism, 2022-12, Vol.57, p.152083-152083, Article 152083

2022

Volltextzugriff (PDF)

The role of immunomodulatory medications in the treatment of COVID-19

Current opinion in rheumatology, 2021-09, Vol.33 (5), p.431-445

2021

Volltextzugriff (PDF)

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Expert review of clinical immunology, 2020-07, Vol.16 (7), p.659-666

2020

Volltextzugriff (PDF)

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured

Arthritis research & therapy, 2022-08, Vol.24 (1), p.1-202, Article 202

2022

Volltextzugriff (PDF)

Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.36-47

2021

Volltextzugriff (PDF)

Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events

Rheumatology (Oxford, England), 2021-05, Vol.60 (5), p.e184-e185

2021

Volltextzugriff (PDF)

Clinical Features of ANCA-Associated Vasculitis in African American Patients in the United States: A Single-Center Medical Records Review Study

Journal of clinical rheumatology, 2022-06, Vol.28 (4), p.212-216

2022

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Rheumatology
(49)
Humans
(33)
Covid-19
(15)
Life Sciences
(10)
Patients
(9)
Female
(8)
Sars-Cov-2
(8)
Rheumatoid Arthritis
(7)
Aged
(6)
Anca-Associated Vasculitis
(6)
Antirheumatic Agents - Therapeutic Use
(6)
Comorbidity
(6)
Coronaviruses
(6)
Male
(6)
Vasculitis
(6)
Adult
(5)
Arthritis
(5)
Glucocorticoids
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

Fracture mortality: associations with epidemiology and osteoporosis treatment

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis

Patient‐Reported Outcomes in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Are the Answers in Front of Our Noses?

Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA‐Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide

Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications

Where did that trial go? Unpublished clinical trials in rheumatology and potential implications

Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?

Navigating use of rituximab during the COVID-19 pandemic

Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention

Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment

Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019

The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the American College of Rheumatology RISE Registry

Current perspective on infections and mitigation strategies in primary systemic vasculitis

Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs – Analysis of a national claims database

The role of immunomodulatory medications in the treatment of COVID-19

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured

Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis

Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events

Clinical Features of ANCA-Associated Vasculitis in African American Patients in the United States: A Single-Center Medical Records Review Study

Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey

Suchergebnisse filtern